In vitro Pb exposure disturbs the balance between Aβ production and elimination: The role of AβPP and neprilysin

Abstract

Metabolism of β-amyloid peptide (Aβ) is closely associated with the pathology and etiology of Alzheimer’s disease (AD). Our previous studies on aging primates and rodents have revealed that early life lead exposure increases the expression of the β-amyloid precursor protein (AβPP), elevates Aβ levels, and promotes neurodegeneration in old age. These effects were attributed to de novo synthetic pathways; however, the impact on Aβ degradation was not explored. Neprilysin (NEP), a rate-limiting catabolic peptidase is involved in Aβ metabolism in vivo. In the present study we sought to investigate whether accumulation of Aβ induced by Pb exposure is partially due to its ability to subdue NEP expression and consequently NEP activity. SH-SY5Y cells were exposed to Pb concentrations of 0, 5, 10, 20, and 50 μM for 48 h and AβPP, NEP protein and mRNA levels were measured. Additionally, NEP enzymatic activity and Aβ levels were also assessed. Western blot and RT-PCR analysis indicated significant increases in the protein and mRNA expression of AβPP, which appeared to be concentration and time-dependent, while the protein and mRNA expression of NEP as well as NEP activity declined. These actions of Pb were specific and were not observed when substituted by another metal. These results suggest that Pb causes both the overexpression of AβPP and repression of NEP resulting in the buildup of Aβ.

Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation

“…SH-SY5Y cells were seeded in a white-walled clear bottom 96-well plate (3000 cells/well) and incubated for 24h in a humidified 37°C incubator with 5% CO 2 . Cell differentiation was induced by treating SH-SY5Y cells with 10 µM all- trans -retinoic acid (RA) for 3 days following established procedures [40,41]. Cell count was performed in randomly selected wells and the mean value was calculated.…”

Alzheimer's Disease with Markedly Elevated Arsenic and Other Metals Masquerading as Organic Brain Syndrome and Affective Disorder

“…High levels of Pb in bone were found to be associated with poor cognitive function in elderly workers in one study [6] although serum Pb levels had no correlation with dementia in another [7]. Nonetheless, a recent study suggests Pb may increase APP levels in cells [23]. The role of Cadmium in development of AD is not established.…”

The Recent Updates of Therapeutic Approaches Against Aβ for the Treatment of Alzheimer's Disease

“…On the other hand, an overloading of the main clearance mechanisms of this peptide from the brain and an increase of its influx into the CNS may also lead to Ab accumulation, aggregation, and neurotoxicity. Among many Ab peptide-degrading enzymes, neprilysin, a membrane-bound zinc metallopeptidase, is considered the most important Ab peptide-degrading enzyme (Huang et al, 2011;Iwata et al, 2001). The neprilysin is capable of breaking down Ab in both intra-and extra-cellular spaces via its active site at the lumen side.…”